Whether low frequency of hepatobiliary abnormalities in cystic fibrosis patients is associated with anti-inflammatory treatment? Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects Year: 2008
Low reliability of RINT in slight symptomatic cystic fibrosis patients Source: Eur Respir J 2001; 18: Suppl. 33, 536s Year: 2001
Outcomes of cystic fibrosis patients after spontaneous pneumothorax Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007
Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020
Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries. Source: International Congress 2019 – Clinical problems Year: 2019
Massive hemoptysis in cystic fibrosis adult patients Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008
Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017 Year: 2018
Pneumothorax in paediatric cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005
Frequency and pathogenicity of rhinovirus associated pulmonary exacerbations in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Relationship between nintedanib exposure and adverse events in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF treatment II Year: 2016
Pregnancy in two patients with cystic fibrosis treated with lumacaftor/ivacaftor Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019
Predictors of massive haemoptysis after a first episode of mild-to-moderate haemoptysis in patients with cystic fibrosis Source: ERJ Open Res, 6 (3) 00382-2020; 10.1183/23120541.00382-2020 Year: 2020
Predictive factors for severe pulmonary exacerbations in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006
Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients Source: Virtual Congress 2021 – Bronchiectasis Year: 2021
Screening for cystic fibrosis among high risk group patients with chronic lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002
Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases Year: 2018
Nasal and sinus problems in cystic fibrosis patients Source: Eur Respir Monogr 2017; 76: 48-66 Year: 2017
Genotype and progressive lung damage in adult cystic fibrosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 502s Year: 2003
Prevalence of hyperglycaemia during infective exacerbation in adult cystic fibrosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007